Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 4 | 4 |
| List of Tables | 7 | 1 |
| List of Figures | 7 | 1 |
| Introduction | 8 | 1 |
| Biobanks The Basics | 9 | 4 |
| Introduction | 9 | 1 |
| Types of Biobanks | 9 | 1 |
| DNA Banks | 9 | 1 |
| Cell Culture Banks | 9 | 1 |
| Pathologically Altered Vital Tissue Banks | 10 | 1 |
| Benefits of Biobanks | 10 | 1 |
| Biobanks - Brief History | 11 | 1 |
| Framingham Heart Study | 11 | 1 |
| Monitoring of Cardiovascular Diseases Project | 12 | 1 |
| Characteristics of a Biobank | 12 | 1 |
| Classification of Biobanks | 12 | 1 |
| Population-Based Biobanks | 12 | 1 |
| Disease-Based Biobanks | 12 | 1 |
| Biobanks Overview | 13 | 10 |
| Introduction | 13 | 1 |
| National Biobanks | 13 | 1 |
| Funding Structure in Biobanking | 13 | 1 |
| Funding Issues | 14 | 1 |
| Private Funding | 14 | 1 |
| Public-Private Funding | 14 | 1 |
| Public Funding | 15 | 1 |
| Partnerships Structure in Biobanking | 16 | 1 |
| Comparison of Partnerships | 17 | 1 |
| Increasing Harmonization | 18 | 1 |
| Biobanks Participating in Harmonization | 18 | 1 |
| Expert Centers Trans-national Research | 19 | 1 |
| Cost of Biobanks | 20 | 1 |
| Sample Collection | 20 | 1 |
| Biobank Set Up | 20 | 1 |
| Maintenance of the Biobank | 20 | 1 |
| Research Costs | 20 | 1 |
| Outreach Activities | 20 | 1 |
| Conclusion | 21 | 1 |
| SWOT Analysis of Biobanking Sector | 21 | 1 |
| Strengths | 21 | 1 |
| Weaknesses | 22 | 1 |
| Opportunities | 22 | 1 |
| Threats | 22 | 1 |
| Biobanks Population-based Biobanks | 23 | 22 |
| Introduction | 23 | 1 |
| Cohort study or Panel Study | 24 | 1 |
| deCODE Genetics | 24 | 1 |
| Background Information | 24 | 1 |
| Organizational Structure | 25 | 1 |
| Financial Support | 25 | 1 |
| Collaborations | 26 | 1 |
| Future Plan | 26 | 1 |
| CARTaGENE | 26 | 1 |
| Background Information | 26 | 1 |
| Organizational Structure | 27 | 1 |
| Financial Support | 27 | 1 |
| Collaborations | 27 | 1 |
| Future Plan | 28 | 1 |
| UK DNA Banking Network | 28 | 1 |
| Background Information | 28 | 1 |
| Organizational Structure | 28 | 1 |
| Financial Support | 29 | 1 |
| Collaborations | 30 | 1 |
| Future Plan | 31 | 1 |
| European Network for Genetic and Genomic Epidemiology (ENGAGE) | 31 | 1 |
| Background Information | 31 | 1 |
| Organizational Structure | 32 | 1 |
| Financial Support | 33 | 1 |
| Collaborations | 33 | 1 |
| Future Plan | 33 | 1 |
| TRANSBIG Network | 34 | 1 |
| Background Information | 34 | 1 |
| Organizational Structure | 35 | 1 |
| Financial Support | 35 | 1 |
| Collaborations | 36 | 1 |
| Future Plan | 36 | 1 |
| Iceland Health Sector Database | 36 | 1 |
| Background Information | 36 | 1 |
| Organizational Structure | 36 | 1 |
| Financial Support | 36 | 1 |
| Collaborations | 36 | 1 |
| Future Plan | 37 | 1 |
| Tumor Bank of Castilla-Leon (BTCyL) | 37 | 1 |
| Background Information | 37 | 1 |
| Organizational Structure | 37 | 1 |
| Financial Support | 38 | 1 |
| Telethon Genetic Biobank Network | 38 | 1 |
| Background Information | 38 | 1 |
| Organizational Structure | 38 | 1 |
| Financial Support | 39 | 1 |
| Collaborations | 39 | 1 |
| Future Plan | 40 | 1 |
| EuroBiobank | 40 | 1 |
| Background Information | 40 | 1 |
| Organizational Structure | 41 | 1 |
| Financial Support | 42 | 1 |
| Collaborations | 42 | 1 |
| Future Plan | 43 | 1 |
| Latvian Biobank | 43 | 1 |
| Background Information | 43 | 1 |
| Organizational Structure | 43 | 1 |
| Financial Support | 43 | 1 |
| Collaborations | 43 | 1 |
| Future Plan | 43 | 1 |
| Canadian Partnership for Tomorrow Project | 43 | 1 |
| Background Information | 43 | 1 |
| Organizational Structure | 43 | 1 |
| Financial Support | 43 | 1 |
| Collaborations | 44 | 1 |
| Future Plan | 44 | 1 |
| Biobanks Disease-Based Biobanks | 45 | 17 |
| Introduction | 45 | 1 |
| Cancer Biobanks | 46 | 1 |
| Victorian Cancer Biobank | 46 | 1 |
| Background Information | 46 | 1 |
| Financial Support | 46 | 1 |
| Future Plan | 46 | 1 |
| The Ontario Tumor Bank | 46 | 1 |
| Background Information | 46 | 1 |
| Financial Support | 47 | 1 |
| Future Plan | 47 | 1 |
| The Canadian Tumor Repository Network | 47 | 1 |
| Background Information | 47 | 1 |
| Financial Support | 47 | 1 |
| Future Plan | 47 | 1 |
| Tumor Tissue Repository | 47 | 1 |
| Background Information | 47 | 1 |
| Financial Support | 48 | 1 |
| Future Plan | 48 | 1 |
| Brain Biobanking | 48 | 1 |
| Huddinge Brain Biobank | 48 | 1 |
| Background Information | 48 | 1 |
| Financial Support | 48 | 1 |
| Future Plan | 48 | 1 |
| MRC London Brain Bank for Neurodegenerative Diseases | 49 | 1 |
| Background Information | 49 | 1 |
| Financial Support | 49 | 1 |
| Future Plan | 49 | 1 |
| The MRC HIV Brain and Tissue Bank | 49 | 1 |
| Background Information | 49 | 1 |
| Financial Support | 49 | 1 |
| Future Plan | 49 | 1 |
| The MRC Sudden Death Brain and Tissue Bank | 50 | 1 |
| Background Information | 50 | 1 |
| Financial Support | 50 | 1 |
| Future Plan | 50 | 1 |
| CJD Brain and Tissue Bank | 50 | 1 |
| Background Information | 50 | 1 |
| Financial Support | 50 | 1 |
| UK Multiple Sclerosis Tissue Bank | 50 | 1 |
| Background Information | 50 | 1 |
| Financial Support | 51 | 1 |
| Future Plan | 51 | 1 |
| South West Dementia Brain Bank | 51 | 1 |
| Background Information | 51 | 1 |
| Financial Support | 51 | 1 |
| Future Plan | 51 | 1 |
| Queen Square Brain Bank for Neurological Disorders | 51 | 1 |
| Background Information | 51 | 1 |
| Financial Support | 52 | 1 |
| Future Plan | 52 | 1 |
| Newcastle Brain Tissue Resource | 52 | 1 |
| Background Information | 52 | 1 |
| Financial Support | 52 | 1 |
| Future Plan | 52 | 1 |
| Twin Registries | 52 | 1 |
| GenomEUTwin | 52 | 1 |
| Background Information | 52 | 1 |
| Financial Support | 52 | 1 |
| Future Plan | 53 | 1 |
| The Australian Twin Registry | 53 | 1 |
| Background Information | 53 | 1 |
| Financial Support | 53 | 1 |
| Future Plan | 53 | 1 |
| The Mid-Atlantic Twin Registry | 54 | 1 |
| Background Information | 54 | 1 |
| Financial Support | 54 | 1 |
| Future Plan | 54 | 1 |
| Stem Cell Biobanking | 55 | 1 |
| The Singapore Stem Cell Consortium | 55 | 1 |
| Background Information | 55 | 1 |
| Financial Support | 55 | 1 |
| Future Plan | 55 | 1 |
| Coriell Stem Cell Biobank | 55 | 1 |
| Background Information | 55 | 1 |
| Financial Support | 55 | 1 |
| Swiss Stem Cells Bank | 56 | 1 |
| Background Information | 56 | 1 |
| Financial Support | 56 | 1 |
| Future Plan | 56 | 1 |
| Children Biobanks | 56 | 1 |
| The Norwegian Mother and Child Cohort Study (MoBa) | 57 | 1 |
| Background Information | 57 | 1 |
| Financial Support | 57 | 1 |
| Future Plan | 57 | 1 |
| Avon Longitudinal Study of Parents and Children (ALSPAC) | 57 | 1 |
| Background Information | 57 | 1 |
| Financial Support | 57 | 1 |
| Future Plan | 57 | 1 |
| Largest Biobanks and Biobanking Networks in the World | 58 | 1 |
| The Public Population Project in Genomics (P3G) | 58 | 1 |
| Background Information | 58 | 1 |
| Financial Support | 58 | 1 |
| Future Plan | 58 | 1 |
| Estonian Genome Project (EGP) | 58 | 1 |
| Background Information | 58 | 1 |
| Financial Support | 59 | 1 |
| Future Plan | 59 | 1 |
| Singapore Tissue Network | 59 | 1 |
| Background Information | 59 | 1 |
| Financial Support | 59 | 1 |
| Future Plan | 59 | 1 |
| UK Biobank | 59 | 1 |
| Background Information | 59 | 1 |
| Financial Support | 60 | 1 |
| Future Plan | 60 | 1 |
| International Genomics Consortium (IGC) | 60 | 1 |
| Background Information | 60 | 1 |
| Financial Support | 61 | 1 |
| Future Plan | 61 | 1 |
| Biobanks Regulatory and Ethical Issues and Challenges | 62 | 3 |
| Introduction | 62 | 1 |
| Issues Related to Biobanking | 62 | 1 |
| Informed Consent | 62 | 1 |
| Confidentiality | 62 | 1 |
| Returning Results from Biobank | 62 | 1 |
| Secondary Use of Samples Collected Over Time | 63 | 1 |
| Challenges Faced by Biobanks | 64 | 1 |
| Conclusions | 64 | 1 |
| Biobanks Appendix | 65 | 5 |
| Market Definitions | 65 | 1 |
| Abbreviations | 65 | 2 |
| Sources | 67 | 1 |
| Research Methodology | 68 | 2 |
| Coverage | 68 | 1 |
| Secondary Research | 68 | 1 |
| Primary Research | 68 | 1 |
| Expert Panel Validation | 69 | 1 |
| Contact Us | 69 | 1 |
| Disclaimer | 69 | 1 |